Calculate SAFE conversions for Amsterdam startups raising from EU and US investors. Master valuation caps, discounts, Innovation Box tax benefits, and Dutch legal considerations.
A SAFE (Simple Agreement for Future Equity) is a financing instrument that allows Amsterdam startups to raise capital from investors without immediately determining valuation or issuing shares. Created by Y Combinator in 2013 and now widely adopted across European tech hubs, SAFEs have become the default early-stage fundraising mechanism for pre-seed and seed rounds.
For Amsterdam-based founders, SAFEs solve a critical challenge: raising capital quickly from both European and US investors without the complexity and legal costs of traditional equity rounds. In 2024, over 60% of Dutch seed-stage startups raised initial capital via SAFE notes, attracted by their simplicity and founder-friendly terms.
Unlike traditional equity financing, a SAFE is a contractual right to receive shares in the future—typically when the company raises a priced equity round (Series A) or experiences a liquidation event. The SAFE converts into equity at that future date based on terms negotiated today: primarily the valuation cap and discount rate.
Understanding how SAFEs convert is essential for Amsterdam founders navigating cross-border fundraising, managing cap tables with multiple investor currencies (EUR and USD), and maintaining compliance with Dutch corporate law.
When you raise capital via SAFE, investors receive neither equity nor debt immediately. Instead, they receive a contractual promise that their investment will convert to equity in the future under specific conditions.
SAFEs typically convert during these events:
The valuation cap is the maximum effective valuation at which your SAFE converts to equity. This protects early investors from dilution if your Series A valuation significantly exceeds expectations.
Example: Amsterdam fintech startup raises €300,000 on a SAFE with €6M valuation cap. Two years later, you raise Series A at €20M pre-money valuation.
The valuation cap rewards early risk-taking by giving SAFE investors more favorable conversion terms than Series A investors.
The discount rate (typically 15-25%) gives SAFE holders the right to convert at a discounted price relative to Series A investors.
Example: Your Amsterdam startup raises €500,000 on SAFE with 20% discount. Series A prices shares at €10.00 per share.
This 20% discount means SAFE investors receive 25% more shares for their investment than Series A investors paying full price.
Most Amsterdam SAFEs include both a valuation cap and discount rate. When the SAFE converts, investors benefit from whichever term is more favorable (typically the valuation cap in high-growth scenarios).
Amsterdam startup valuations have matured significantly as the Dutch tech ecosystem scales. Here are current market benchmarks for SAFE terms:
How does Amsterdam compare to other European tech hubs for SAFE valuations?
Amsterdam sits in the European upper-middle tier: higher than Berlin and Stockholm, competitive with Paris, but below London's inflated valuations.
SAFE Terms:
Series A Details:
SAFE Conversion Calculation:
Result: SAFE investors receive 180,180 shares representing approximately 5% ownership (before Series A dilution). Series A investors buying at €18M pre-money get 2.22% for their €400K equivalent investment—SAFE investors get 2.25x more equity.
SAFE Terms:
Series A Details:
SAFE Conversion Calculation:
Result: SAFE investors receive 20% more shares than if they invested at Series A pricing. For the same €250,000, Series A investors would receive only 55,556 shares (€250,000 ÷ €4.50).
SAFE Terms:
Series A Details:
SAFE Conversion Calculation:
Investors benefit from the more favorable term. Let's compare:
Option A - Using Valuation Cap:
Option B - Using 20% Discount:
Result: Valuation cap is more favorable. SAFE investors convert at €10M cap, receiving 187,500 shares (6% ownership). Without the cap, they would receive only 93,750 shares. The cap delivers 2x more equity in this high-growth scenario.
Amsterdam startups frequently raise from both European (EUR-denominated) and US (USD-denominated) investors, creating currency complexity in SAFE management.
Most Amsterdam founders should structure SAFEs in EUR if:
Accept USD-denominated SAFEs when:
Amsterdam startups with both EUR and USD SAFEs must track conversion carefully:
Example: Amsterdam startup raises €300K EUR SAFE and $300K USD SAFE, both at €8M / $9M caps. At SAFE issuance, exchange rate is 1.10 USD/EUR. At Series A conversion two years later, rate is 1.05 USD/EUR.
EUR strengthening caused USD SAFE holders to receive slightly less equity. Documenting this currency risk upfront prevents disputes at conversion.
While SAFEs originated in the US under Delaware law, Amsterdam startups using Dutch BV (Besloten Vennootschap) structure must ensure SAFE terms comply with Netherlands corporate law.
When SAFEs convert to equity, Dutch law requires a notarial deed to transfer shares. Budget €1,000-€2,500 in notary costs for SAFE conversion during Series A. Many Amsterdam law firms (Benvalor, Axite, VBAT) offer startup packages bundling SAFE conversion with Series A documentation.
Dutch BVs typically include shareholder pre-emption rights in articles of association. SAFE agreements should include provision that existing shareholders waive pre-emption rights for SAFE conversion, avoiding delays when SAFEs convert to equity.
SAFE conversions often require board approval and potentially shareholder approval depending on your articles of association. Work with Dutch startup counsel to ensure SAFE agreements align with governance requirements.
US-based Y Combinator SAFE templates require modifications for Dutch law compliance:
Experienced Amsterdam startup lawyers (VBAT, Benvalor, CMS Netherlands) provide Netherlands-specific SAFE templates that maintain economic terms while ensuring Dutch legal compliance.
The Netherlands offers one of Europe's most founder-friendly tax regimes for startups, particularly through the Innovation Box (Innovatiebox) incentive.
The Innovation Box allows Dutch companies to apply a 9% corporate tax rate (instead of standard 25.8%) on profits derived from qualifying intellectual property—patents, software, and qualifying R&D.
For Amsterdam startups raising via SAFE and developing patentable technology, the Innovation Box creates significant value:
Under Dutch tax law, SAFE issuances are generally not taxable events for either the company or investors. Key considerations:
Amsterdam founders should structure equity carefully before raising SAFEs to minimize tax on future dilution:
Understanding which Amsterdam and European investors actively use SAFEs helps founders target fundraising effectively.
Conservative Amsterdam founders sometimes accept low valuation caps (€3M-€4M at seed) to close deals quickly. If you achieve strong traction and raise Series A at €15M-€20M, that low cap causes massive dilution.
Example: You raise €500K at €4M cap. Series A prices at €18M. SAFE converts at €4M cap, giving SAFE holders 12.5% of company. Had you negotiated €8M cap, dilution would be only 6.25%.
Solution: Research comparable Amsterdam startup valuations. Don't accept caps below €5M-€6M at seed unless you're truly pre-product with no traction.
Some SAFE investors negotiate pro-rata rights—the option to invest in future rounds to maintain ownership percentage. This limits how much equity you can offer Series A investors.
Example: Your €1M SAFE round includes 5 investors with pro-rata rights totaling 10% ownership post-conversion. At Series A, if all exercise pro-rata, they consume allocation you intended for new lead investors, potentially killing the round.
Solution: Only grant pro-rata rights to strategic angels and key early investors. Side letters can formalize this without cluttering the SAFE agreement.
Raising multiple SAFE rounds with different caps (€6M, €8M, €10M) and discounts (15%, 20%, 25%) creates cap table complexity and potential investor disputes at conversion.
Solution: Standardize SAFE terms within each fundraising period (3-6 months). If you raise multiple tranches, consider converting earlier SAFEs into later terms or clearly communicate to all parties that terms will differ.
MFN clauses give early SAFE investors the right to adopt more favorable terms from later SAFEs. If your first SAFE has €6M cap with no MFN, and your second SAFE offers €8M cap, early investors can't upgrade.
However, if the first SAFE includes MFN, early investors automatically get €8M cap, increasing dilution.
Solution: Understand MFN implications. If you expect improving traction to justify higher caps, don't grant MFN on earliest SAFEs.
Amsterdam founders should model SAFE conversion scenarios before closing any SAFE investment. Here's a practical framework:
Before any SAFE raise, document:
Create scenarios for Series A at:
For each scenario, calculate:
Typical Amsterdam Series A rounds raise €3M-€8M at 20-30% dilution. Model total dilution from both SAFE conversion and Series A new money.
Example:
Amsterdam startups should use dedicated cap table software:
Despite their popularity, SAFEs aren't always the right fundraising instrument:
Institutional European VCs investing €2M+ at seed typically require priced equity rounds with full due diligence, board seats, and protective provisions. SAFEs are too simple for these governance-heavy rounds.
Better Alternative: Price your Series Seed as formal equity round with clear valuation, investor rights, and governance terms.
SAFEs work when conversion is reasonably certain within 18-24 months. If you're building a capital-efficient business that may not need Series A, SAFEs create cap table uncertainty.
Better Alternative: Raise traditional equity or consider revenue-based financing if you're profitable/near-profitable.
SAFEs don't grant governance rights. Strategic investors wanting board observation rights or veto power over key decisions require priced equity rounds with investor rights agreements.
Better Alternative: Structure as priced equity with side letter granting specific governance rights.
Before SAFEs gained popularity, convertible notes were the standard bridge financing instrument. Some Amsterdam investors still prefer convertible notes. Here's the comparison:
For most Amsterdam startups raising €200K-€1.5M at pre-seed and seed, SAFEs are preferable. They're founder-friendly, widely understood by European investors, and simpler to administer under Dutch law.
Choose convertible notes only if investors specifically require them or you need the forcing mechanism of a maturity date to stay disciplined about fundraising timeline.
Amsterdam seed-stage startups raising via SAFE typically negotiate valuation caps between €5M-€12M in 2025. Pre-seed rounds (pre-product or minimal traction) range €2M-€5M caps. Seed rounds with demonstrated product-market fit and €200K-€500K ARR command €8M-€15M caps. Amsterdam caps are generally 10-20% lower than London but 15-25% higher than Berlin.
Amsterdam startups should default to EUR-denominated SAFEs if the majority of capital is raised from European investors and your Series A will likely be led by a European VC. Accept USD SAFEs from US investors who require them, but track currency exposure carefully and model conversion scenarios at different exchange rates. Mixed-currency cap tables are manageable but add complexity.
Amsterdam startups eligible for Innovation Box treatment (9% tax rate on IP-derived profits vs. 25.8% standard rate) can justify 10-15% higher valuations when negotiating SAFE caps. The tax advantage increases after-tax cash flows and long-term investor returns. Deeptech and software startups with patentable innovations should highlight Innovation Box eligibility during fundraising to support higher caps.
Yes, but standard US SAFE templates require modifications for Dutch BV structures. Work with Netherlands startup lawyers (VBAT, Benvalor, CMS Netherlands) to adapt SAFE terms for Dutch corporate law compliance, including proper share transfer procedures, pre-emption right waivers, and notarial deed requirements at conversion. Budget €2,000-€5,000 for Dutch legal review and customization.
If your startup is acquired before SAFEs convert to equity, SAFE holders typically receive payout based on the liquidation preference terms in the SAFE agreement. Most SAFEs give investors 1x preference (they receive their investment amount back before any payout to founders) or conversion at the valuation cap (whichever is more favorable). This protects early investors in acquisition scenarios.
Calculate each SAFE cohort's dilution separately based on their respective caps, then sum total dilution. Example: (1) €300K SAFE at €6M cap = 5% dilution, (2) €400K SAFE at €8M cap = 5% dilution, (3) €500K SAFE at €10M cap = 5% dilution. Total SAFE dilution = 15%. Then calculate Series A dilution separately and apply sequentially. Use cap table software (Carta, Pulley) to model complex scenarios accurately.
Mastering SAFE mechanics is essential for Amsterdam founders navigating cross-border fundraising in Europe's increasingly competitive tech ecosystem. Understanding how valuation caps and discounts affect your cap table, modeling conversion scenarios before signing term sheets, and structuring SAFEs to comply with Dutch corporate law separates sophisticated founders from those who discover dilution surprises at Series A.
Amsterdam's position as a leading European fintech and deeptech hub, combined with the Netherlands' founder-friendly Innovation Box regime and 30% ruling for talent, makes it an ideal environment for building high-growth startups. But access to capital requires fluency in modern fundraising instruments—and in 2025, that means SAFEs.
Whether you're raising your first €300K from Amsterdam angels or closing a €1.5M seed round with European VCs, precise SAFE calculation ensures you preserve equity, maintain control, and position your startup for a successful Series A.
Ready to model your SAFE conversion scenarios and understand exactly how your Amsterdam fundraising will affect your cap table? Use our free Amsterdam SAFE calculator to input your terms, model multiple Series A valuation scenarios, and calculate precise dilution across different investor currencies.
Try our free startup calculators to make informed decisions about your equity and fundraising.
Explore Calculators →